Teva share price struggles to recover following $6 billion market loss Posted by NOWlej | Feb 18, 2025 | Israel NOWlej | 0 | The financial results were actually positive, at the higher end of analysts’ forecasts, but profit guidance for 2025 disappointed the market. | Read More in JPost.com – Business & Innovation. Read More in Israel NOWlej.